New laboratory techniques for the assessment of acquired immunobullous disorders

Summary This review aims to summarize investigations that are used in the assessment of patients with suspected immunobullous disorders. Emphasis is placed upon new adaptations of existing techniques and the advent of recombinant technology, which has enabled the production of synthetic antigens. The use of recombinant antigens has provided the latest generation of diagnostic techniques that are likely to make a major impact on routine diagnosis of immunobullous disorders.

[1]  T. Nishikawa,et al.  Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. , 2000, The Journal of investigative dermatology.

[2]  R. Hoffmann,et al.  The Prevalence of Antibodies against Desmoglein 1 in Endemic Pemphigus Foliaceus in Brazil , 2000 .

[3]  S. Challacombe,et al.  The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus , 2000, The British journal of dermatology.

[4]  M. Amagai,et al.  Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus , 2000, Experimental dermatology.

[5]  S. Challacombe,et al.  Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3 , 2000, Clinical and experimental dermatology.

[6]  M. Black,et al.  Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. , 1999, Clinical immunology.

[7]  Eady,et al.  Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy , 1999, The British journal of dermatology.

[8]  Komai,et al.  Usefulness of enzyme‐linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus , 1999, The British journal of dermatology.

[9]  H. Shimizu,et al.  New insights into the immunoultrastructural organization of cutaneous basement membrane zone molecules , 1998, Experimental dermatology.

[10]  Allen,et al.  Blister fluid for the diagnosis of subepidermal immunobullous diseases: a comparative study of basement membrane zone autoantibodies detected in blister fluid and serum , 1998, The British journal of dermatology.

[11]  T. Nishikawa,et al.  A Case of Unique Subepidermal Blistering Disease with Autoantibodies against a Novel Dermal 200-kD Antigen , 1998, Dermatology.

[12]  M. Kiss,et al.  The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. , 1998, European journal of dermatology : EJD.

[13]  T. Nishikawa,et al.  Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. , 1998, The Journal of investigative dermatology.

[14]  S. M. Ewing,et al.  A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. , 1997, The Journal of investigative dermatology.

[15]  D. Zillikens,et al.  Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. , 1997, The Journal of investigative dermatology.

[16]  J. Nicolas,et al.  Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. , 1997, Archives of dermatology.

[17]  T. Nishikawa,et al.  Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. , 1997, Journal of immunology.

[18]  T. Nishikawa,et al.  Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. , 1997, The Journal of investigative dermatology.

[19]  Mei Chen,et al.  Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. , 1997, The Journal of investigative dermatology.

[20]  J. R. McMillan,et al.  Mutations in the 180–kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa , 1995, Nature Genetics.

[21]  T. Nishikawa,et al.  Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. , 1995, The Journal of investigative dermatology.

[22]  R. Eady,et al.  The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases , 1995, Journal of cutaneous pathology.

[23]  Marcel,et al.  180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. , 1995, The Journal of clinical investigation.

[24]  F. Wojnarowska,et al.  Autoimmune blistering diseases: an up‐date of diagnostic methods and investigations , 1994, Clinical and experimental dermatology.

[25]  H. Shimizu.  Recent advances in electron microscopic immunocytochemistry in dermatology , 1993 .

[26]  P. Joly,et al.  [Paraneoplastic pemphigus]. , 1993, Presse medicale.

[27]  L. Diaz,et al.  Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. , 1992, The Journal of investigative dermatology.

[28]  M M Black,et al.  An ultrastructural comparison of dermo‐epidermal separation techniques , 1991, Journal of cutaneous pathology.

[29]  R. Phelps,et al.  Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin. , 1991, The Journal of investigative dermatology.

[30]  S. Kim,et al.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia , 1991, The New England journal of medicine.

[31]  M. Black,et al.  Diagnosis, diagnostic and research techniques , 1990 .

[32]  F. Wojnarowska,et al.  The use of chemically split tissue in the detection of circulating anti‐basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid , 1988, The British journal of dermatology.

[33]  A. Inman,et al.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. , 1984, The Journal of investigative dermatology.

[34]  E. Beutner,et al.  Demonstration of Skin Antibodies in Sera of Pemphigus Vulgaris Patients by Indirect Immunofluorescent Staining.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.